GE Healthcare has completed the acquisition of Puridify, a bioprocessing start-up that is developing a nanofiber-based platform purification technology for biopharmaceutical production. Puridify’s technology, Fibro Select, is complementary to the bead resins and chromatography membranes used today in downstream bioprocessing.
Read on